AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16463825 — intervention group
Group type: COMPARATOR
Intervention: Neurotrend
Number of subjects: 7
Study 12190099 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 137
Study 12190099 — intervention group
Group type: COMPARATOR
Intervention: Observation (watchful waiting)
Number of subjects: 137
Study 12190099 — intervention group
Group type: COMPARATOR
Intervention: Excluded patients
Number of subjects: 137
Study 10633323 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher wellness program for two years
Number of subjects: 32
Study 8543495 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem (1 g every 8 h, infusion or bolus)
Number of subjects: 232
Study 8543495 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin (1 g every 8 h, infusion)
Number of subjects: 232
Study 8543495 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 232
Study 8543495 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 232
Study 8543495 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem and Imipenem/cilastatin
Number of subjects: 232
Study 1741532 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal nasal ventilation (NNV) for 3 months
Number of subjects: 19
Study 1741532 — intervention group
Group type: COMPARATOR
Intervention: Standard care for 3 months
Number of subjects: 19
Study 1741532 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal nasal ventilation (NNV)
Number of subjects: 19
Study 30801532 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow cellular EVLP system
Number of subjects: 16
Study 30801532 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow acellular EVLP system
Number of subjects: 16
Study 30801532 — intervention group
Group type: COMPARATOR
Intervention: Controls with CIT <8 hours
Number of subjects: 16
Study 30840384 — intervention group
Group type: COMPARATOR
Intervention: Daily low-dose antioxidant supplementation (vitamins and minerals) for 7.5 years
Number of subjects: 0
Study 30840384 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26552852 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression CAREPATH intervention (integrated depression care management into routine nursing visits)
Number of subjects: 306
Study 26552852 — intervention group
Group type: COMPARATOR
Intervention: Usual care (enhanced usual care)
Number of subjects: 306
Study 23962141 — intervention group
Group type: EXPERIMENTAL
Intervention: Wakefulness (no nap)
Number of subjects: 30
Study 23962141 — intervention group
Group type: COMPARATOR
Intervention: Napping
Number of subjects: 30
Study 23044257 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote endarterectomy (RE)
Number of subjects: 95
Study 23044257 — intervention group
Group type: COMPARATOR
Intervention: Endovascular (ENDO)
Number of subjects: 95
Study 19935424 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold Equalizing Noise (TEN) test
Number of subjects: 20
Study 19935424 — intervention group
Group type: EXPERIMENTAL
Intervention: fast-PTC technique
Number of subjects: 20
Study 19935424 — intervention group
Group type: EXPERIMENTAL
Intervention: TEN test
Number of subjects: 20
Study 19935424 — intervention group
Group type: EXPERIMENTAL
Intervention: fast-PTC test
Number of subjects: 20
Study 18021288 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel diaries for 2 weeks
Number of subjects: 278
Study 18021288 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel symptom questionnaire
Number of subjects: 278
Study 18021288 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowel diaries and symptom questionnaires
Number of subjects: 278
Study 15796636 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal construct group therapy
Number of subjects: 42
Study 15796636 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 42
Study 12006142 — intervention group
Group type: EXPERIMENTAL
Intervention: Clickhaler (2 x 200 microg actuations)
Number of subjects: 15
Study 12006142 — intervention group
Group type: COMPARATOR
Intervention: Turbuhaler (2 x 200 microg actuations)
Number of subjects: 15
Study 10483843 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamphetamine
Number of subjects: 68
Study 10483843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 7805903 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline, 100 mg twice per day for 14 days
Number of subjects: 41
Study 7805903 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim 160 mg-sulfamethoxazole 800 mg twice per day for 14 days
Number of subjects: 41
Study 7805903 — intervention group
Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 41
Study 1659268 — intervention group
Group type: EXPERIMENTAL
Intervention: LTC4
Number of subjects: 13
Study 1659268 — intervention group
Group type: EXPERIMENTAL
Intervention: LTD4
Number of subjects: 13
Study 1659268 — intervention group
Group type: EXPERIMENTAL
Intervention: LTE4
Number of subjects: 13
Study 1659268 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 13
Study 1659268 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 13
Study 1659268 — intervention group
Group type: COMPARATOR
Intervention: LTC4, LTD4, LTE4, Methacholine (Control for Normal Subjects)
Number of subjects: 13
Study 7179201 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (200 mg b.i.d.)
Number of subjects: 150
Study 7179201 — intervention group
Group type: COMPARATOR
Intervention: Acenocoumarol (controlled by thrombotest)
Number of subjects: 150
Study 7179201 — intervention group
Group type: COMPARATOR
Intervention: Acenocoumarol
Number of subjects: 150
Study 7179201 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen
Number of subjects: 150
Study 30281778 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical traction maneuver (Amr's maneuver) for 90 seconds after placental delivery in conjunction with active management of the third stage of labor (AMTSL)
Number of subjects: 852
Study 30281778 — intervention group
Group type: COMPARATOR
Intervention: Active management of the third stage of labor (AMTSL)
Number of subjects: 852
Study 28612363 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 154
Study 28612363 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental health education (DHE)
Number of subjects: 154
Study 28612363 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental health education and planning (DHE&P)
Number of subjects: 154
Study 28612363 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (TAU, DHE, DHE&P)
Number of subjects: 154
Study 26537815 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI group
Number of subjects: 440
Study 26537815 — intervention group
Group type: COMPARATOR
Intervention: Conventional mean arterial pressure (control group)
Number of subjects: 440
Study 22695241 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) for 5 postoperative days with additional oral intake ad libitum
Number of subjects: 157
Study 22695241 — intervention group
Group type: COMPARATOR
Intervention: Oral nutrition alone
Number of subjects: 157
Study 21281519 — intervention group
Group type: EXPERIMENTAL
Intervention: Client-centred, caseworker delivered smoking cessation intervention
Number of subjects: 0
Study 21281519 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 19276766 — intervention group
Group type: EXPERIMENTAL
Intervention: StrataGraft skin substitute
Number of subjects: 15
Study 19276766 — intervention group
Group type: COMPARATOR
Intervention: Cryopreserved cadaver allograft
Number of subjects: 15
Study 17978968 — intervention group
Group type: EXPERIMENTAL
Intervention: Student teachers
Number of subjects: 59
Study 17978968 — intervention group
Group type: COMPARATOR
Intervention: Associate professors
Number of subjects: 59
Study 15738292 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine
Number of subjects: 26
Study 12469362 — intervention group
Group type: EXPERIMENTAL
Intervention: nateglinide 120 mg three times daily
Number of subjects: 43
Study 12469362 — intervention group
Group type: EXPERIMENTAL
Intervention: glibenclamide 5 mg once or twice daily
Number of subjects: 43
Study 12469362 — intervention group
Group type: EXPERIMENTAL
Intervention: nateglinide and glibenclamide
Number of subjects: 43
Study 11774671 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mmol/L nitrous oxide
Number of subjects: 112
Study 11774671 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mmol/L nitrous oxide with estazolam
Number of subjects: 112
Study 11774671 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mmol/L nitrous oxide
Number of subjects: 112
Study 11774671 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mmol/L nitrous oxide with estazolam
Number of subjects: 112
Study 11774671 — intervention group
Group type: COMPARATOR
Intervention: Control group (local anaesthesia only)
Number of subjects: 112
Study 8140662 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambu Twin Pump 1000
Number of subjects: 0
Study 2643282 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release nicardipine (40 mg twice a day)
Number of subjects: 16
Study 2643282 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice a day)
Number of subjects: 16
Study 4834373 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 5 ml/kg
Number of subjects: 0
Study 4834373 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 10 ml/kg
Number of subjects: 0
Study 4834373 — intervention group
Group type: EXPERIMENTAL
Intervention: Changing from small to large tidal volume
Number of subjects: 0
Study 31034084 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotypic tropism testing (GTT)
Number of subjects: 396
Study 31034084 — intervention group
Group type: COMPARATOR
Intervention: Phenotypic tropism testing (Trofile)
Number of subjects: 396
Study 31034084 — intervention group
Group type: EXPERIMENTAL
Intervention: Both assays (GTT and Trofile)
Number of subjects: 396
Study 27988142 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg once daily for 10 weeks
Number of subjects: 174
Study 27988142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 27988142 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgotinib (all doses)
Number of subjects: 174
Study 26011042 — intervention group
Group type: EXPERIMENTAL
Intervention: Barefoot running
Number of subjects: 35
Study 26011042 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncushioned minimalist shoes
Number of subjects: 35
Study 26011042 — intervention group
Group type: EXPERIMENTAL
Intervention: Cushioned minimalist shoes
Number of subjects: 35
Study 26011042 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard running shoes
Number of subjects: 35
Study 24165696 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5-mg etanercept
Number of subjects: 49
Study 24165696 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5-mg etanercept
Number of subjects: 49
Study 24165696 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5-mg etanercept
Number of subjects: 49
Study 24165696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 22204799 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MT) 5 mg twice daily
Number of subjects: 42
Study 22204799 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan (TRP) 250 mg twice daily
Number of subjects: 42
Study 22204799 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg twice daily + placebo
Number of subjects: 42
Study 18815039 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 24
Study 18815039 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study 18815039 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition
Number of subjects: 24
Study 17351193 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid stenting
Number of subjects: 0
Study 17351193 — intervention group
Group type: COMPARATOR
Intervention: Standard carotid endarterectomy
Number of subjects: 0
Study 15379414 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult stretched penile length (SPL)
Number of subjects: 22
Study 15379414 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval SPL growth between diagnosis and adulthood
Number of subjects: 22
Study 15379414 — intervention group
Group type: COMPARATOR
Intervention: Questionnaire responses (Social Adjustment Self Report Questionnaire and Hopkins Symptom Checklist)
Number of subjects: 22
Study 11533324 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy plus acetazolamide (100 mg/kg/d) and furosemide (1 mg/kg/d)
Number of subjects: 177
Study 11533324 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 177
Study 11533324 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy plus acetazolamide and furosemide
Number of subjects: 177
Study 9604144 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg/2 ml ampul)
Number of subjects: 70
Study 9604144 — intervention group
Group type: COMPARATOR
Intervention: Morphine (10 mg/1 ml ampul)
Number of subjects: 70
Study 9604144 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol and Morphine
Number of subjects: 70
Study 9604144 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 70
Study 9604144 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol
Number of subjects: 70
Study 8064075 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 15 mg twice daily for 3 weeks
Number of subjects: 16
Study 8064075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 2456421 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-verbal feedback
Number of subjects: 30
Study 2456421 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal-quantitative feedback
Number of subjects: 30
Study 2456421 — intervention group
Group type: COMPARATOR
Intervention: Verbal-qualitative feedback
Number of subjects: 30
Study 31828287 — intervention group
Group type: EXPERIMENTAL
Intervention: 4gOBG (10 g oat-bran)
Number of subjects: 28
Study 31828287 — intervention group
Group type: EXPERIMENTAL
Intervention: 2gOBG (3 g oat-bran)
Number of subjects: 28
Study 31828287 — intervention group
Group type: EXPERIMENTAL
Intervention: 4gloMW (10 g oat-bran plus β-glucanase)
Number of subjects: 28
Study 31828287 — intervention group
Group type: COMPARATOR
Intervention: CR (Cream of Rice)
Number of subjects: 28
Study 30317337 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular tranexamic acid (1.5 gm)
Number of subjects: 140
Study 30317337 — intervention group
Group type: COMPARATOR
Intervention: Intravenous tranexamic acid (1.5 gm)
Number of subjects: 140
Study 28006041 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus fluocinolone (n=223)
Number of subjects: 662
Study 28006041 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin (n=221)
Number of subjects: 662
Study 28006041 — intervention group
Group type: COMPARATOR
Intervention: Fluocinolone (n=218)
Number of subjects: 662
Study 26589146 — intervention group
Group type: EXPERIMENTAL
Intervention: Worsened mental health after cessation (measured by SF-36, scored 0-100)
Number of subjects: 0
Study 26589146 — intervention group
Group type: COMPARATOR
Intervention: No change or improvement in mental health after cessation
Number of subjects: 0
Study 23392916 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mA anodal transcranial direct current stimulation (tDCS)
Number of subjects: 20
Study 23392916 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study 23392916 — intervention group
Group type: COMPARATOR
Intervention: Comparison between anodal tDCS and sham tDCS
Number of subjects: 20
Study 21549568 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 82
Study 21549568 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 82
Study 21549568 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 82
Study 21549568 — intervention group
Group type: COMPARATOR
Intervention: Control for glucose and triglyceride levels, anticholinergic side effects, medication serum levels, cholesterol lowering medications, and pre‐study antipsychotic medications
Number of subjects: 82
Study 18461894 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX, 2%)
Number of subjects: 385
Study 18461894 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-colistin (CHX-COL, 2%-2%)
Number of subjects: 385
Study 18461894 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 385
Study 16934640 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care, limited ultrasonography (PLUS)
Number of subjects: 262
Study 16934640 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 262
Study 12664023 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanned CO(2) laser followed by Q-switched ruby laser (QSRL)
Number of subjects: 13
Study 12664023 — intervention group
Group type: COMPARATOR
Intervention: Q-switched ruby laser (QSRL) alone
Number of subjects: 13
Study 10334433 — intervention group
Group type: EXPERIMENTAL
Intervention: Omacor (n-3 fatty acids) 5.1 g/day
Number of subjects: 500
Study 10334433 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (placebo)
Number of subjects: 500
Study 8921101 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg dexamethasone (group B; n = 27)
Number of subjects: 78
Study 8921101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg dexamethasone (group C; n = 27)
Number of subjects: 78
Study 8921101 — intervention group
Group type: COMPARATOR
Intervention: Control group (group A; n = 24)
Number of subjects: 78
Study 2317426 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural anaesthesia (EA)
Number of subjects: 32
Study 2317426 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (GA)
Number of subjects: 32
Study 759126 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate ointment
Number of subjects: 195
Study 759126 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone dipropionate cream
Number of subjects: 195
Study 31678935 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based, multi-faceted intervention lasting 9 months, including activities for students, parents, and school environment, supported by a smartphone application.
Number of subjects: 1200
Study 31678935 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (control group)
Number of subjects: 1200
Study 26013241 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloramine gel (Perisolv™) applied locally followed by mechanical instrumentation
Number of subjects: 18
Study 26013241 — intervention group
Group type: COMPARATOR
Intervention: Conventional non-surgical mechanical debridement
Number of subjects: 18
Study 25227897 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with fluorouracil and levamisole (5‐FU/Lev)
Number of subjects: 380
Study 25227897 — intervention group
Group type: COMPARATOR
Intervention: Control (surgery only)
Number of subjects: 380
Study 24402038 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry extract (36 mg proanthocyanidins per day) taken twice daily for 1 year
Number of subjects: 171
Study 24402038 — intervention group
Group type: COMPARATOR
Intervention: Placebo taken twice daily for 1 year
Number of subjects: 171
Study 22583007 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 65
Study 22583007 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproic acid
Number of subjects: 65
Study 22583007 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 65
Study 22583007 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight
Number of subjects: 65
Study 22583007 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 65
Study 18688212 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cannabis (1-8% Delta-9-tetrahydrocannabinol), four times daily for 5 consecutive days
Number of subjects: 34
Study 18688212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 17550933 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (400 microg bid)
Number of subjects: 24
Study 17550933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 15837996 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant regimen (day 1: APR 125 mg, OND 8 mg, dexamethasone 12 mg; days 2-3: APR 80 mg qd)
Number of subjects: 857
Study 15837996 — intervention group
Group type: COMPARATOR
Intervention: Control regimen (day 1: OND 8 mg, dexamethasone 20 mg; days 2-3: OND 8 mg bid)
Number of subjects: 857
Study 12623503 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose polyestradiol phosphate (PEP) 240 mg i.m. twice a month for 2 months and thereafter once a month
Number of subjects: 917
Study 12623503 — intervention group
Group type: COMPARATOR
Intervention: Combined androgen deprivation (CAD) with flutamide (Eulexin) 250 mg t.i.d. and triptorelin (Decapeptyl) 3.75 mg per month i.m. or bilateral orchidectomy
Number of subjects: 917
Study 9864885 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper-bearing IUD (380 mm2)
Number of subjects: 0
Study 9864885 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper-bearing IUD (200 mm2)
Number of subjects: 0
Study 9864885 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper-bearing IUD (375 mm2)
Number of subjects: 0
Study 9864885 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper-bearing IUD (250 mm2)
Number of subjects: 0
Study 9864885 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-IUD users)
Number of subjects: 0
Study 7696066 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam 20 mg orally as premedication
Number of subjects: 47
Study 7696066 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of anaesthesia with propofol or thiopentone
Number of subjects: 47
Study 7696066 — intervention group
Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 47
Study 2966613 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline 75 mg with alcohol (1 g/kg)
Number of subjects: 12
Study 2966613 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxepin 25 mg with alcohol (1 g/kg)
Number of subjects: 12